The Art of Bioimmunogenomics (BIGs) 5.0 in CAR-T Cell Therapy for Lymphoma Management.

Dito AnurogoDewi LuthfianaNuralfin AnripaApriliani Ismi FauziahMaratu SolehaLaila RahmahHana RatnawatiTeresa Liliana WargasetiaSari Eka PratiwiRiswal Nafi SiregarRatis Nour SholichahMuhammad Sobri MaulanaTaruna IkrarYu Hsiang ChangJiantai Timothy Qiu

Published in: Advanced pharmaceutical bulletin (2024)

While the efficacy and safety of CAR-T cell immunotherapy remain subjects of fervent investigation, the promise of this cutting-edge technology offers valuable insights for the future evolution of lymphoma treatment management approaches. Moreover, CAR-T cell therapies potentially benefit patients, motivating regulatory bodies to foster international collaboration.

Keyphrases

end stage renal disease
diffuse large b cell lymphoma
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
transcription factor
machine learning
current status
hiv infected
antiretroviral therapy